CL Willman
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 12
- Acute Myeloid Leukemia Research 12
- Chronic Myeloid Leukemia Treatments 4
- Multiple Myeloma Research and Treatments 3
- Platelet Disorders and Treatments 2
- Genetics 4
- Chronic Lymphocytic Leukemia Research 4
- Journals
- Blood (8 papers)Leukemia (2 papers)Oncogene (1 paper)PubMed (4 papers)
- Partner nations
- United StatesSouth Africa
In The Last Decade
CL Willman
15 papers receiving 460 citations
Peers
Comparison fields: 5 of 45
- Hematology 334
- Genetics 90
- Public Health, Environmental and Occupational Health 129
- Molecular Biology 256
- Oncology 83
Countries citing papers authored by CL Willman
This map shows the geographic impact of CL Willman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CL Willman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CL Willman more than expected).
Fields of papers citing papers by CL Willman
This network shows the impact of papers produced by CL Willman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CL Willman. The network helps show where CL Willman may publish in the future.
Co-authors
The 16 scholars most cited alongside CL Willman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 11 | |
| 2 | 1999 | 24 | |
| 3 | Molecular evaluation of acute myeloid leukemias. | 1999 | 21 |
| 4 | Acute leukemias: a paradigm for the integration of new technologies in diagnosis and classification. | 1999 | 15 |
| 5 | Alien Attacks Dog | 1995 | 1 |
| 6 | 1993 | 134 | |
| 7 | 1993 | 7 | |
| 8 | 1992 | 44 | |
| 9 | 1992 | 3 | |
| 10 | 1991 | 3 | |
| 11 | 1991 | 44 | |
| 12 | Multiparameter analysis of acute mixed lineage leukemia: correlation of a B/myeloid immunophenotype and immunoglobulin and T-cell receptor gene rearrangements with the presence of the Philadelphia chromosome translocation in acute leukemias with myeloid morphology. | 1991 | 17 |
| 13 | The molecular biology of acute myeloid leukemia. Proto-oncogene expression and function in normal and neoplastic myeloid cells. | 1990 | 13 |
| 14 | 1990 | 131 | |
| 15 | 1990 | 4 |
About CL Willman
CL Willman is a scholar working on Hematology, Genetics, Infectious Diseases, Public Health, Environmental and Occupational Health and Molecular Biology, having authored 15 papers that have together received 472 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (12 papers), Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Multiple Myeloma Research and Treatments (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Platelet Disorders and Treatments (2 papers), HIV/AIDS drug development and treatment (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Hematology (334 citations), Genetics (90 citations), Public Health, Environmental and Occupational Health (129 citations), Molecular Biology (256 citations) and Oncology (83 citations). CL Willman has collaborated with scholars based in United States and South Africa. Frequent co-authors include KJ Kopecky, David Head, SJ Collins, F R Appelbaum, James K. Weick, ML Cleary, MD Amylon, MP Link, SP Hunger and AJ Carroll. Their work appears in journals such as Blood, Leukemia, Oncogene and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.